• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . The characteristics and clinical course of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2020 Oct 27;S1201-9712(20)32255-4.
doi: 10.1016/j.ijid.2020.10.051. Online ahead of print.
The characteristics and clinical course of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan


Atsushi Hirayama[SUP] 1 [/SUP], Jun Masui[SUP] 2 [/SUP], Ayumi Murayama[SUP] 3 [/SUP], Satomi Fujita[SUP] 4 [/SUP], Jun Okamoto[SUP] 5 [/SUP], Jun Tanaka[SUP] 6 [/SUP], Takanori Hirayama[SUP] 7 [/SUP], Toshitake Ohara[SUP] 8 [/SUP], Emma Nakagawa Hoffmann[SUP] 9 [/SUP], Jingwen Zhang[SUP] 10 [/SUP], Haruna Kawachi[SUP] 11 [/SUP], Hideo Okuno[SUP] 12 [/SUP], Shigeto Hamaguchi[SUP] 13 [/SUP], Kazunori Tomono[SUP] 14 [/SUP], Rumiko Asada[SUP] 15 [/SUP]



Affiliations

Abstract

Objective: To describe the detailed clinical course of patients with coronavirus disease 2019 (COVID-19) who received invasive mechanical ventilation.
Methods: We conducted a case series of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan between January 29 and May 28, 2020. We described the patient characteristics and clinical course from onset. Additionally, we fitted logistic regression models to investigate the associations between patient characteristics and 30-day mortality rate.
Results: A total of 125 patients who received invasive mechanical ventilation (median age [IQR], 68 [57-73]; men, 77.6%) were enrolled. Overall, the 30-day mortality rate was 24.0%, and the median (IQR) length of ICU stay and length of invasive mechanical ventilation use were 16 (12-29) and 13 (9-26), respectively. From clinical onset, 121 (96.8%) patients were intubated within 14 days. In multivariable logistic regression analysis, aged ≥65 years (OR, 3.56; 95% CI, 1.21-10.49; P = 0.02) and male sex (OR, 3.75; 95% CI, 1.00-11.24, P = 0.04) were significantly associated with a higher 30-day mortality rate.
Conclusions: In this case series of patients with COVID-19 who received invasive mechanical ventilation in Japan, the 30-day mortality rate was 24.0% and those aged ≥65 years and men were associated with higher 30-day mortality rate.

Keywords: 30-day mortality rate; COVID-19; Epidemiology; Invasive mechanical ventilation.
 
Back
Top Bottom